MTMT-ben szereplő publikációk tallózása szerző szerint "Lázár, Bernadette"

A találatok rendezése: Rendezés: Találatok:

  • Efficacy-based perspective to overcome reduced opioid analgesia of advanced painful diabetic neuropathy in rats 
    Balogh, Mihály; Zádor, Ferenc; Zádori, S. Zoltán; Shaqura, Mohammed; Király, Kornél P.; Mohammadzadeh, Amir; Varga, K. Bence; Lázár, Bernadette; Mousa, A. Shaaban; Hosztafi, Sándor; Riba, Pál; Benyhe, Sándor; Gyires, Klára; Schäfer, Michael; Fürst, Susanna; Al-Khrasani, Mahmoud (2019)
    Reduction of the opioid analgesia in diabetic neuropathic pain (DNP) results from mu-opioid receptor (MOR) reserve reduction. Herein, we examined the antinociceptive and antiallodynic actions of a novel opioid agonist ...
  • Hidden Cardiotoxicity of Rofecoxib Can be Revealed in Experimental Models of Ischemia/Reperfusion 
    Brenner, Gábor B; Makkos, András; Nagy, Csilla Terézia; Onódi, Zsófia; Sayour, Nabil V; Gergely, Tamás G; Kiss, Bernadett; Görbe, Anikó; Sághy, Éva; Zádori, Zoltán Sándor; Lázár, Bernadette; Baranyai, Tamás; Varga, Richárd S; Husti, Zoltán; Varró, András; Tóthfalusi, László; Schulz, Rainer; Baczkó, István; Giricz, Zoltán; Ferdinandy, Péter (2020)
    Cardiac adverse effects are among the leading causes of the discontinuation of clinical trials and the withdrawal of drugs from the market. The novel concept of 'hidden cardiotoxicity' is defined as cardiotoxicity of a ...
  • Lack of Small Intestinal Dysbiosis Following Long-Term Selective Inhibition of Cyclooxygenase-2 by Rofecoxib in the Rat 
    Lázár, Bernadette; Brenner, Gábor; Makkos, András; Balogh, Mihály; László, Szilvia Bianka; Al-Khrasani, Mahmoud; Hutka, Barbara; Bató, Emese; Ostorházi, Eszter; Juhász, János; Kemény, Ágnes; Horváthné László, Terézia; Tiszlavicz, László; Bihari, Zoltán; Giricz, Zoltán; Szabó, Dóra; Helyes, Zsuzsanna; Ferdinandy, Péter; Gyires, Klára; Zádori, Zoltán S (2019)
    Intestinal dysbiosis is linked to numerous gastrointestinal disorders, including inflammatory bowel diseases. It is a question of debate if coxibs, selective inhibitors of cyclooxygenase (COX)-2, cause dysbiosis. Therefore, ...